Zika Virus–Associated Guillain-Barré Syndrome in a Returning US Traveler

Zika virus (ZIKV) infection has been associated with Guillain-Barré syndrome (GBS). Roughly 60% of people in countries such as the United States live in areas at risk of seasonal spread of ZIKV. Zika virus belongs to a class of diseases that is not typically seen in hospital settings across the United States and Europe. We describe the case presentation, management, and treatment of ZIKV infection complicated by GBS. A 64-year-old woman with recent travel to the Dominican Republic presented with rash followed by an acute, ascending polyneuropathy consistent with GBS. She was confirmed to have an acute ZIKV infection by detection of ZIKV nucleic acid by reverse transcription–polymerase chain reaction. She met Brighton Collaboration criteria level 1 evidence for GBS. She received 2 courses of intravenous immunoglobulin and slowly improved, but still had weakness at discharge. More research is needed to identify the pathophysiology behind ZIKV-associated GBS and its optimal treatment. Prevention is fundamental to limiting infection and spread of ZIKV. Correspondence to: Anna Nolan, MD, MS, Division of Pulmonary, Critical Care and Sleep, New York University School of Medicine, New Bellevue, 7N Room 24, 462 1st Ave, New York, NY 10016. E-mail: anna.nolan@med.nyu.edu. All authors were involved in the data collection and analysis and review of the literature. All authors participated in writing and revision of the report and approval of the final version. Source(s) of Support: NIH/NHLBI R01HL119326. The authors have no conflicts of interest to disclose. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

https://ift.tt/2jWRRg1